Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by SANOFI AVENTIS US
FDA Drug Application 020164 by SANOFI AVENTIS US
Application Number
020164
Application Type
New Drug Application
Sponsor Applicant
SANOFI AVENTIS US
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New molecular entity (NME)
Therapeutic Potential
Priority
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
3/29/1993
N
7714
000
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/pre96/20-164ltr.pdf
2/25/2004
AP
0
3/29/1993
N
8196
000
http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/20-164_lbl.pdf
4/5/2004
AP
0
3/29/1993
N
9747
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/20-164_review.pdf
7/15/2004
AP
0
3/29/1993
N
37718
000
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm373741.htm
11/7/2013
AP
0
3/14/1994
SLR
AP
0
3/9/1995
SE1
AP
0
3/15/1996
SCM
20573
004
http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020164_S004_LOVENOX_INJECTION.pdf
8/11/2008
AP
0
1/30/1996
SLR
20572
005
http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020164_S005_LOVENOX INJ.pdf
8/11/2008
AP
0
5/27/1997
SLR
AP
0
3/7/1997
SCP
AP
0
5/6/1997
SE1
AP
0
6/26/1996
SCP
20571
009
http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020164_S009_LOVENOX INJ.pdf
8/11/2008
AP
0
1/30/1998
SE1
5510
010
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20164S10_lovenox.cfm
4/29/2003
AP
0
1/30/1998
SE1
9184
010
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20164S10_lovenox_approv.pdf
6/8/2004
AP
0
2/24/1998
SCS
20546
011
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020164_S011_LOVENOX.pdf
8/8/2008
AP
0
10/23/1996
SCM
20570
012
http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020164_S012_LOVENOX_INJECTION.pdf
8/11/2008
AP
0
5/16/1997
SCM
20560
013
http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020164_S013_LOVENOX_INJECTION.pdf
8/11/2008
AP
0
1/27/1997
SLR
AP
0
12/31/1998
SE1
377
015
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20164S15_Lovenox.cfm
7/3/2000
AP
0
12/31/1998
SE1
378
015
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20164s15ltr.pdf
12/31/1998
AP
0
12/31/1998
SE1
379
015
http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20164s15lbl.pdf
12/31/1998
AP
0
3/27/1998
SE1
AP
0
5/27/1997
SLR
AP
0
3/3/1999
SCP
20531
019
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020164_S019_LOVENOX.pdf
8/8/2008
AP
0
8/3/2000
SE8
2758
020
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20164S20LTR.PDF
8/4/2000
AP
0
4/20/1999
SLR
20530
021
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020164_S021_LOVENOX.pdf
8/8/2008
AP
0
7/21/1999
SCS
20529
022
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020164_S022_LOVENOX.pdf
8/8/2008
AP
0
11/8/1999
SCM
20528
023
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020164_S023_LOVENOX_INJECTION.pdf
8/8/2008
AP
0
7/22/1999
SCS
20527
024
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020164_S024_LOVENOX.pdf
8/8/2008
AP
0
9/14/1999
SCS
20526
026
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020164_S026_LOVENOX.pdf
8/8/2008
AP
0
10/5/1999
SCS
AP
0
9/28/1999
SLR
AP
0
6/2/2000
SCF
20489
030
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020164_S030_LOVENOX_INJECTION.pdf
8/4/2008
AP
0
10/5/1999
SLR
AP
0
1/27/2000
SCM
20488
032
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020164_S032_LOVENOX_INJECTION.pdf
8/4/2008
AP
0
5/30/2000
SE8
2757
034
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20164S34ltr.pdf
9/27/2000
AP
0
4/4/2000
SCP
AP
0
11/17/2000
SE1
1479
036
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20164S36ltr.pdf
11/17/2000
AP
0
11/17/2000
SE1
1480
036
http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20164S36lbl.pdf
11/17/2000
AP
0
11/17/2000
SLR
1538
037
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20164S36ltr.pdf
11/17/2000
AP
0
11/17/2000
SLR
1539
037
http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20164S36lbl.pdf
11/17/2000
AP
0
6/20/2000
SCM
20487
038
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020164_S038_LOVENOX_INJECTION.pdf
8/4/2008
AP
0
10/24/2000
SCS
20486
039
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020164_S039_LOVENOX_INJECTION.pdf
8/4/2008
AP
0
1/9/2002
SLR
2754
040
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20164s40s45s46ltr.pdf
1/9/2002
AP
0
1/9/2002
SLR
20452
040
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020164_S040&045&046_LOVENOX INJ.pdf
8/4/2008
AP
0
12/14/2000
SCM
20485
041
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020164_S041_LOVENOX_INJECTION.pdf
8/4/2008
AP
0
7/5/2001
SCM
20468
042
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/020164_S042_LOVENOX_INJECTION.pdf
8/4/2008
AP
0
1/23/2003
SCM
4767
043
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20164scm043ltr.pdf
1/23/2003
AP
0
1/23/2003
SCM
20431
043
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020164_S043_LOVENOX_INJECTION.pdf
8/1/2008
AP
0
11/30/2001
SCS
20466
044
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/020164_S044_LOVENOX INJ.pdf
8/4/2008
AP
0
1/9/2002
SLR
2755
045
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20164s40s45s46ltr.pdf
1/9/2002
AP
0
1/9/2002
SLR
20453
045
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020164_S040&045&046_LOVENOX INJ.pdf
8/4/2008
AP
0
1/9/2002
SLR
2756
046
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20164s40s45s46ltr.pdf
1/9/2002
AP
0
1/9/2002
SLR
20454
046
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020164_S040&045&046_LOVENOX INJ.pdf
8/4/2008
AP
0
12/18/2003
SLR
7346
048
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20164slr048ltr.pdf
12/23/2003
AP
0
7/1/2003
SLR
6094
050
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20164slr050ltr.pdf
7/8/2003
AP
0
7/1/2003
SLR
20430
050
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020164_S050_LOVENOX INJ.pdf
8/1/2008
AP
0
6/20/2003
SLR
6045
051
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20164slr051ltr.pdf
7/6/2003
AP
0
6/20/2003
SLR
20429
051
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020164_S051_LOVENOX INJ.pdf
8/1/2008
AP
0
10/20/2004
SCM
10461
053
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20164s053ltr.pdf
10/26/2004
AP
0
7/23/2004
SCS
9858
055
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20164s055ltr.pdf
7/28/2004
AP
0
7/23/2004
SCS
9874
055
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20164s055lbl.pdf
7/28/2004
AP
0
7/23/2004
SCS
15276
055
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020164_S055_Lovenox_Approval_Package.pdf
10/26/2006
AP
0
4/13/2004
SLR
8373
056
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20164slr056ltr.pdf
4/20/2004
AP
0
4/13/2004
SLR
20421
056
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020164_S056_LOVENOX INJ.pdf
8/1/2008
AP
0
5/18/2004
SLR
8659
057
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20164slr057ltr.pdf
5/26/2004
AP
0
5/18/2004
SLR
17153
057
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020164_S057_LOVENOX INJECION_AP.pdf
7/9/2007
AP
0
4/21/2004
SLR
8440
058
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20164slr058ltr.pdf
4/29/2004
AP
0
4/21/2004
SLR
17152
058
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020164_S058_LOVENOX INJECTION_AP.pdf
7/9/2007
AP
0
3/7/2005
SLR
11224
063
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/20164s063ltr.pdf
3/10/2005
AP
0
1/12/2007
SCP
15657
070
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020164s070lbl.pdf
1/16/2007
AP
0
1/12/2007
SCP
15663
070
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020164s070ltr.pdf
1/16/2007
AP
0
5/16/2007
SLR
16618
075
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022138s000,020164s075ltr.pdf
5/29/2007
AP
0
5/16/2007
SLR
16626
075
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022138,020164s075lbl.pdf
5/29/2007
AP
0
5/16/2007
SLR
22082
075
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022138_020164_lovenox_enoxaparin_sodium_toc.cfm
3/24/2009
AP
0
12/10/2012
SCM
AP
0
7/16/2008
SLR
20258
080
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020164s080ltr.pdf
7/18/2008
AP
0
7/16/2008
SLR
20266
080
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020164s080lbl.pdf
7/22/2008
AP
0
7/23/2009
SLR
23091
083
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020164s083lbl.pdf
7/30/2009
AP
0
7/23/2009
SLR
23100
083
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020164s083ltr.pdf
7/31/2009
AP
0
12/23/2009
SLR
24373
085
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020164s085lbl.pdf
12/30/2009
AP
0
12/23/2009
SLR
24380
085
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020164s085ltr.pdf
12/31/2009
AP
0
12/6/2012
SCM
AP
0
4/13/2011
SLR
28544
092
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020164s092ltr.pdf
4/15/2011
AP
0
4/13/2011
SLR
28580
092
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020164s092lbl.pdf
4/19/2011
AP
0
4/20/2011
SLR
28594
093
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020164s093lbl.pdf
4/21/2011
AP
0
4/20/2011
SLR
28597
093
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020164s093ltr.pdf
4/22/2011
AP
0
9/6/2013
SCM
AP
0
11/28/2012
SCM
AP
0
6/5/2013
SLR
36241
100
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020164Orig1s100ltr.pdf
6/7/2013
AP
0
6/5/2013
SLR
36272
100
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020164s100lbl.pdf
6/11/2013
AP
0
10/23/2013
SLR
37560
102
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020164Orig1s102ltr.pdf
10/25/2013
AP
0
10/23/2013
SLR
37631
102
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020164s102lbl.pdf
10/31/2013
AP
0
9/27/2013
SCM
AP
0
5/29/2014
SCM
AP
0
8/3/2015
SCM
AP
0
8/24/2015
SCM
Back to FDA Applications sponsored by SANOFI AVENTIS US